论文部分内容阅读
目的探讨稳定型心绞痛患者行口服麝香保心丸至少6个月的临床疗效。方法 80例稳定型心绞痛患者随机分为观察组与对照组,各40例。对照组行常规治疗,观察组在其基础上口服麝香保心丸至少6个月,对比两组患者临床疗效。结果观察组心绞痛症状缓解情况明显优于对照组,差异具有统计学意义(P<0.05);对照组不良反应发生率为45.0%明显高于观察组的12.5%,差异具有统计学意义(P<0.05)。结论稳定型心绞痛患者行口服麝香保心丸至少6个月的效果显著,不良反应较少,值得临床推广。
Objective To investigate the clinical efficacy of oral musk pill in patients with stable angina for at least 6 months. Methods Eighty patients with stable angina were randomly divided into observation group and control group, 40 cases in each. Control group routine treatment, the observation group on the basis of oral musk pill for at least 6 months, compared the clinical efficacy of two groups of patients. Results The relief of angina pectoris in the observation group was significantly better than that in the control group (P <0.05). The incidence of adverse reactions in the control group was 45.0%, significantly higher than that in the observation group (12.5%, P < 0.05). Conclusions Patients with stable angina pectoris have the effect of oral administration of musk pill at least 6 months, with less adverse reactions, which is worthy of clinical promotion.